Restifo NP - Search Results

1

Chappell DB, Restifo NP. Chappell DB, et al. Among authors: restifo np. Cancer Immunol Immunother. 1998 Oct;47(2):65-71. doi: 10.1007/s002620050505. Cancer Immunol Immunother. 1998. PMID: 9769114 Free PMC article. Review.

2

Murine tumor cells transduced with the gene for tumor necrosis factor-alpha. Evidence for paracrine immune effects of tumor necrosis factor against tumors.

Asher AL, Mulé JJ, Kasid A, Restifo NP, Salo JC, Reichert CM, Jaffe G, Fendly B, Kriegler M, Rosenberg SA. Asher AL, et al. Among authors: restifo np. J Immunol. 1991 May 1;146(9):3227-34. J Immunol. 1991. PMID: 2016545 Free PMC article.

3

Recognition of neuroectodermal tumors by melanoma-specific cytotoxic T lymphocytes: evidence for antigen sharing by tumors derived from the neural crest.

Shamamian P, Mancini M, Kawakami Y, Restifo NP, Rosenberg SA, Topalian SL. Shamamian P, et al. Among authors: restifo np. Cancer Immunol Immunother. 1994 Aug;39(2):73-83. doi: 10.1007/BF01525312. Cancer Immunol Immunother. 1994. PMID: 7519127 Free PMC article.

4

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP. Wang M, et al. Among authors: restifo np. J Immunol. 1995 May 1;154(9):4685-92. J Immunol. 1995. PMID: 7722321 Free PMC article.

5

Treatment of established lung metastases with tumor-infiltrating lymphocytes derived from a poorly immunogenic tumor engineered to secrete human TNF-alpha.

Marincola FM, Ettinghausen S, Cohen PA, Cheshire LB, Restifo NP, Mulé JJ, Rosenberg SA. Marincola FM, et al. Among authors: restifo np. J Immunol. 1994 Apr 1;152(7):3500-13. J Immunol. 1994. PMID: 8144931 Free PMC article.

6

Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I.

Restifo NP, Kawakami Y, Marincola F, Shamamian P, Taggarse A, Esquivel F, Rosenberg SA. Restifo NP, et al. J Immunother Emphasis Tumor Immunol. 1993 Oct;14(3):182-90. doi: 10.1097/00002371-199310000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8297900 Free PMC article. Review.

7

Retroviral transduction of interferon-gamma cDNA into a nonimmunogenic murine fibrosarcoma: generation of T cells in draining lymph nodes capable of treating established parental metastatic tumor.

Shiloni E, Karp SE, Custer MC, Shilyansky J, Restifo NP, Rosenberg SA, Mulé JJ. Shiloni E, et al. Among authors: restifo np. Cancer Immunol Immunother. 1993 Oct;37(5):286-92. doi: 10.1007/BF01518450. Cancer Immunol Immunother. 1993. PMID: 8402732 Free PMC article.

8

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP. Rao JB, et al. Among authors: restifo np. J Immunol. 1996 May 1;156(9):3357-65. J Immunol. 1996. PMID: 8617961 Free PMC article.

9

Anti-tumor activity of cytotoxic T lymphocytes elicited with recombinant and synthetic forms of a model tumor-associated antigen.

Wang M, Chen PW, Bronte V, Rosenberg SA, Restifo NP. Wang M, et al. Among authors: restifo np. J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):139-46. doi: 10.1097/00002371-199510000-00001. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8770769 Free PMC article.

10

The next wave of recombinant and synthetic anticancer vaccines.

Irvine KR, Restifo NP. Irvine KR, et al. Among authors: restifo np. Semin Cancer Biol. 1995 Dec;6(6):337-47. doi: 10.1016/1044-579x(95)90003-9. Semin Cancer Biol. 1995. PMID: 8938272 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page